Effects of a Serious Game on Knowledge, Attitude and Practice in Vector Control and Dengue Prevention Among Adults in Primary Care
Launched by SINGHEALTH POLYCLINICS · Mar 29, 2022
Trial Information
Current as of May 21, 2025
Completed
Keywords
ClinConnect Summary
Study design: From March to August 2021, a single-centre randomised controlled trial was conducted to determine the effectiveness of playing a serious game (intervention) in improving the KAP of participants in vector control and dengue prevention compared to those who viewed a dengue prevention website (control).
Study site: This study was conducted at a regional public primary care clinic (Polyclinic) in Sengkang. Sengkang Polyclinic is located in Sengkang Community Hub, which is an amenity centre in Sengkang, within the North-East region of Singapore. Sengkang is also a residential town...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult who is visiting Sengkang Polyclinic.
- • Able to understand English.
- • Has a mobile phone which was compatible with the serious game and willing to download and attempt the serious game.
- • Able to complete questionnaires on the online secured platform, Form.sg.
- Exclusion Criteria:
- • Adult who is not able to use a mobile phone due to physical or cognitive impairments.
About Singhealth Polyclinics
SingHealth Polyclinics is a leading healthcare provider in Singapore, dedicated to delivering high-quality, community-based medical services. As a part of the SingHealth group, the largest healthcare network in the country, it plays a pivotal role in clinical research and trials aimed at improving patient care and advancing medical knowledge. With a commitment to evidence-based practice, SingHealth Polyclinics actively engages in innovative clinical studies that address a wide range of health issues, fostering collaboration among healthcare professionals and researchers to enhance treatment outcomes and community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Patients applied
Trial Officials
Alon Tan
Principal Investigator
SingHealth Polyclinics
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials